CN1739708A - Externally applied medicine of cannalike dona rhizome - Google Patents

Externally applied medicine of cannalike dona rhizome Download PDF

Info

Publication number
CN1739708A
CN1739708A CN 200510098931 CN200510098931A CN1739708A CN 1739708 A CN1739708 A CN 1739708A CN 200510098931 CN200510098931 CN 200510098931 CN 200510098931 A CN200510098931 A CN 200510098931A CN 1739708 A CN1739708 A CN 1739708A
Authority
CN
China
Prior art keywords
radix
parts
medicine
externally applied
traumatic injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510098931
Other languages
Chinese (zh)
Other versions
CN100518784C (en
Inventor
王浩贵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100989310A priority Critical patent/CN100518784C/en
Publication of CN1739708A publication Critical patent/CN1739708A/en
Application granted granted Critical
Publication of CN100518784C publication Critical patent/CN100518784C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention is one kind of externally applied medicine. The medicine is prepared with five kinds of Chinese medicinal materials including cannalike dona rhizome, dragon's blood, lanceleaf anisetree root, common mappianthus stem and beautiful sweetgum root in certain proportion as well as alcohol solution in 75 % concentration. The synergistic effect of the Chinese medicinal materials makes the externally applied medicine possess high and determined effect and short treatment period on traumatic injury, rheumatalgia, rheumarthritis, soft tissue injury and other diseases.

Description

A kind of Radix Zanthoxyli Planispini medicine for external use
Technical field:
The present invention relates to a kind of Radix Zanthoxyli Planispini medicine for external use.
Background technology:
The traumatic injury disease is a kind of common disease, it is a lot of from ancient times to the present to suffer from the somebody, be subjected to ailing the torment deeply, the various medicine for external use of Xiao Shouing are also a lot of in the market, but no matter be Western medicine or Chinese medicine, slight illness for this class Drug therapy traumatic injury has played certain therapeutical effect really, but does not also have a kind of specific drug of ideal treatment traumatic injury.
Summary of the invention:
The inventor is at above-mentioned weak point, and it is convenient to have a kind of treatment at pressing for of patient, eutherapeutic medicine for external use; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compare with existing similar medicine for external use curative effect, better efficacy is a kind of medicine for external use of very ideal traumatic injury.
Purpose of the present invention just provides a kind of Radix Zanthoxyli Planispini medicine for external use.
Choice of drug Radix Zanthoxyli Planispini of the present invention, Sanguis Draxonis, Radix Illicii Lanceolati, Radix Saposhnikoviae, Radix Antenoronis Filiformis, Caulis Mappianthi Iodoidis, Radix Liquidambaris, ethanol (concentration is 75%) are formed; Wherein select Radix Zanthoxyli Planispini for use: have expelling wind and cold, promoting blood circulation and stopping pain; Control traumatic injury, rheumatic arthritis.Select Sanguis Draxonis for use: have the dissipating blood stasis analgesic therapy, the pain relieving granulation promoting; Control traumatic injury, internal injury pain, trauma bones and muscles pain.Select Radix Illicii Lanceolati for use: have eliminating stasis to stop pain, dispelling wind and removing obstruction in the collateral; Control traumatic injury, rheumatic arthralgia.Select Radix Saposhnikoviae for use: have expelling wind and dampness, deliver pain relieving; Control anemofrigid-damp arthralgia, joint is ached.Select Radix Antenoronis Filiformis for use: have eliminating stasis to stop pain, detumescence is invigorated blood circulation; Control traumatic injury, traumatic injury muscles and bones is hindered.Select Caulis Mappianthi Iodoidis for use: have expelling wind and removing dampness, pain relieving is active; Dispelling the wind and dampness pathogens arthralgia, rheumatoid arthritis.Select Radix Liquidambaris for use: have expelling wind and removing dampness.Dispelling the wind and dampness pathogens arthralgia.Make the effect of each medicine produce collaborative effect these drug regimens, thereby can realize effectively treating that traumatic injury, rheumatalgia, lumbocrural pain, joint aches, traumatic injury muscles and bones are hindered, joint is ached, blood stasis swells and ache, the curative effect of disease of soft tissue contusion, articular sprain, rheumatic arthritis, rheumatic arthritis pain, treating swelling and pain by traumatic injury is definite, the course of treatment is shorter, and effect is better.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
Radix Zanthoxyli Planispini 1-15 part, Sanguis Draxonis 1-12 part, Radix Illicii Lanceolati 1-12 part, Radix Saposhnikoviae 1-12 part, Radix Antenoronis Filiformis 1-6 part, Caulis Mappianthi Iodoidis 1-12 part, Radix Liquidambaris 1-12 part, ethanol (concentration is 75%) 30-260 part.
Optimization formula of the present invention is:
13 parts of Radix Zanthoxyli Planispinis, 10 parts of Sanguis Draxonis, 10 parts of Radix Illicii Lanceolatis, 10 parts of Radix Saposhnikoviaes, 4 parts of Radix Antenoronis Filiformiss, 10 parts of Caulis Mappianthi Iodoidiss, 10 parts of Radix Liquidambariss, concentration of alcohol are 75%) 220 parts.
A kind of Radix Zanthoxyli Planispini medicine for external use of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be applicable to that treatment traumatic injury, rheumatalgia, lumbocrural pain, joint aches, traumatic injury muscles and bones are hindered, joint is ached, blood stasis swells and ache, the disease of soft tissue contusion, articular sprain, rheumatic arthritis, rheumatic arthritis pain, treating swelling and pain by traumatic injury; Be a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compares a kind of Radix Zanthoxyli Planispini medicine for external use of better efficacy with existing similar medicine for external use curative effect.Radix Zanthoxyli Planispini medicine for external use of the present invention was once done a large amount of clinical trials in early stage, inferior between the 1992-2005 to over one hundred example on the patient treatment case, comprise be used for the treatment of that traumatic injury, rheumatalgia, lumbocrural pain, joint aches, traumatic injury muscles and bones are hindered, joint is ached, blood stasis swells and ache, the disease of soft tissue contusion, articular sprain, rheumatic arthritis, rheumatic arthritis pain, treating swelling and pain by traumatic injury, do not see untoward reaction during the treatment.Total effective rate is more than 83%, and the treatment works well.
Using method:
This medicine is a medicine for external use, and oral administration is cleaned the affected part with hot water, dabs in the affected part with the drenched medicinal liquid of absorbent cotton, rub with the hands or the tip-tap affected part with the palm of the hand then, and be good to making the affected part heating, every day 3-6 time.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of Radix Zanthoxyli Planispini medicine for external use provided by the present invention is made up of the component of following parts by weight; Radix Zanthoxyli Planispini 1-15 part, Sanguis Draxonis 1-12 part, Radix Illicii Lanceolati 1-12 part, Radix Saposhnikoviae 1-12 part, Radix Antenoronis Filiformis 1-6 part, Caulis Mappianthi Iodoidis 1-12 part, Radix Liquidambaris 1-12 part, ethanol (concentration is 75%) 30-260 part.
Embodiment 2:
Optimization formula of the present invention is:
13 parts of Radix Zanthoxyli Planispinis, 10 parts of Sanguis Draxonis, 10 parts of Radix Illicii Lanceolatis, 10 parts of Radix Saposhnikoviaes, 4 parts of Radix Antenoronis Filiformiss, 10 parts of Caulis Mappianthi Iodoidiss, 10 parts of Radix Liquidambariss, 220 parts of ethanol (concentration is 75%).
Preparation method of the present invention is: at first with above-mentioned Radix Zanthoxyli Planispini, Sanguis Draxonis, Radix Illicii Lanceolati, Caulis Mappianthi Iodoidis, Radix Liquidambaris, the single granularity control of grinding into is as the grain of rice between the size respectively, granule after each single pulverizing is mixed in proportion mixes together evenly, be placed in the container then, and allocate ethanol (concentration is 75%) into, stir in the sealed container of back, according to the modern Chinese medicine processing technology or after soaking 15 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.

Claims (3)

1, a kind of Radix Zanthoxyli Planispini medicine for external use is characterized in that: Radix Zanthoxyli Planispini, Sanguis Draxonis, Radix Illicii Lanceolati, Caulis Mappianthi Iodoidis, Radix Liquidambaris, ethanol (concentration is 75%) are formed.
2, a kind of Radix Zanthoxyli Planispini medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; Radix Zanthoxyli Planispini 1-15 part, Sanguis Draxonis 1-12 part, Radix Illicii Lanceolati 1-12 part, Radix Saposhnikoviae 1-12 part, Radix Antenoronis Filiformis 1-6 part, Caulis Mappianthi Iodoidis 1-12 part, Radix Liquidambaris 1-12 part, ethanol 30-260 part.
3, a kind of Radix Zanthoxyli Planispini medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; 13 parts of Radix Zanthoxyli Planispinis, 10 parts of Sanguis Draxonis, 10 parts of Radix Illicii Lanceolatis, 10 parts of Radix Saposhnikoviaes, 4 parts of Radix Antenoronis Filiformiss, 10 parts of Caulis Mappianthi Iodoidiss, 10 parts of Radix Liquidambariss, 220 parts of ethanol.
CNB2005100989310A 2005-09-11 2005-09-11 Externally applied medicine of traumatic injury, rheumatic arthralgia Expired - Fee Related CN100518784C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100989310A CN100518784C (en) 2005-09-11 2005-09-11 Externally applied medicine of traumatic injury, rheumatic arthralgia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100989310A CN100518784C (en) 2005-09-11 2005-09-11 Externally applied medicine of traumatic injury, rheumatic arthralgia

Publications (2)

Publication Number Publication Date
CN1739708A true CN1739708A (en) 2006-03-01
CN100518784C CN100518784C (en) 2009-07-29

Family

ID=36092333

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100989310A Expired - Fee Related CN100518784C (en) 2005-09-11 2005-09-11 Externally applied medicine of traumatic injury, rheumatic arthralgia

Country Status (1)

Country Link
CN (1) CN100518784C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103356789A (en) * 2013-07-22 2013-10-23 兰州理工大学 Zanthoxylum armatum total alkaloids extract, and preparation method and application thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103356789A (en) * 2013-07-22 2013-10-23 兰州理工大学 Zanthoxylum armatum total alkaloids extract, and preparation method and application thereof

Also Published As

Publication number Publication date
CN100518784C (en) 2009-07-29

Similar Documents

Publication Publication Date Title
CN1813944A (en) External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals
CN100551418C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN100518784C (en) Externally applied medicine of traumatic injury, rheumatic arthralgia
CN1739693A (en) Externally applied medicine of dunn tongoloa root
CN1739624A (en) Externally applied medicine of aizoon stonecrop root
CN1813992A (en) Radix-zauthoxyli-Plamispini external-use collateral-flow-activating medicine for treating injuries from falls
CN1739711A (en) Externally applied medicine of rhodiola root
CN1813928A (en) External-use drug of canavalia gladiata for traumatic injury and activating collaterals
CN1742801A (en) Qianjinba external-use medicine
CN1813898A (en) External-use medicine of hayberry bark for traumatic injury and activating collaterals
CN1762469A (en) Externally applied medicine of madeira vine
CN1751709A (en) External use medicine for treating traumatic injury
CN1739649A (en) Externally applied wound treating medicine of miquel brookweed
CN1742856A (en) Radix aconitic kusnezoffii external-use medicine
CN100518791C (en) Externally applied medicine of traumatic injury, rheumatic arthralgiaf
CN100542549C (en) A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis
CN1739646A (en) Externally applied medicine of thickleaf croton root
CN1739726A (en) Externally applied medicine of champion bauhinia stem
CN1739644A (en) Externally applied medicine of fortune silene herb
CN1739636A (en) Externally applied medicine of Chinese tinospora stem
CN100534512C (en) Externally applied medicine of Yunan camptandra root
CN100534475C (en) Externally applied medicine of sequin lobelia
CN1739634A (en) Externally applied medicine of safflower
CN1813974A (en) Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Acanthopanacis Trifoliati
CN1813963A (en) External medicine of Herbaet Rhizoma Begoniae cavalerei for treating traumatic injuries and activating collateral flows

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090729